Progyny, INC Form 4 insider transactions

Progyny, Inc. Director Kevin K. Gordon has reported the acquisition of 8,026 restricted stock units and 40,649 stock options as part of his compensation, aligning his interests with shareholders.

Progyny, Inc. Director Jeffrey G. Park reported the acquisition of 9,364 restricted stock units and 41,100 stock options on May 22, 2025, increasing his beneficial ownership in the company.

Progyny, Inc. Director Debra L. Morris acquired 3,591 stock options with an exercise price of $20.89, granted on May 22, 2025, in lieu of a $40,000 annual cash retainer for board service, with vesting scheduled for May 22, 2026.

Progyny, Inc. Director Roger C. Holstein was granted 8,026 restricted stock units and options to purchase 37,234 shares of common stock on May 22, 2025, as part of his compensation.

Progyny, Inc. Director Lloyd H. Dean has reported the acquisition of 8,026 restricted stock units and 33,817 stock options as part of compensation, vesting over time.

Progyny, Inc. Director Norman Payson has reported the acquisition of 6,689 restricted stock units and 30,401 stock options, effective May 22, 2025, as part of his compensation.

Progyny, Inc. Director Elizabeth D. Bierbower was granted 44,000 stock options with an exercise price of $20.89, vesting over four years.

Melissa Cummings, Chief Operating Officer of Progyny, Inc., reports acquisition of shares and stock options.

David J. Schlanger, Executive Chairman of Progyny, Inc., sold shares to cover withholding taxes upon the vesting of restricted stock units.

Progyny's CEO, Peter Anevski, reports a transaction involving common stock related to the vesting of restricted stock units.

EVP, GC of Progyny, Allison Swartz, reports acquisition of stock options and restricted stock units, as well as disposal of shares for tax obligations.

Peter Anevski, CEO of Progyny, Inc., reports the acquisition of restricted stock units and stock options as part of an annual merit grant.

Progyny's CFO, Mark Livingston, reports the acquisition and disposal of company stock and stock options.

Progyny's President, Michael E. Sturmer, disposed of shares to cover withholding taxes upon the vesting of restricted stock units.

Allison Swartz, EVP, GC of Progyny, Inc., reports the disposition of 1,551 shares of common stock to cover withholding taxes upon vesting of restricted stock units on February 28, 2025.

Progyny Inc.'s President, Michael E Sturmer, reports disposition of shares to cover tax obligations related to vesting of restricted stock units.

Mark Livingston, CFO of Progyny, Inc., reports the disposition of 181 shares of common stock to cover withholding taxes upon the vesting of restricted stock units.

Progyny director Debra L. Morris acquired 44,000 stock options at an exercise price of $20.62 on January 16, 2025.

David J. Schlanger, Executive Chairman of Progyny, Inc., reports disposition of shares to cover withholding taxes upon vesting of restricted stock units.

Progyny's CEO, Peter Anevski, sold 6,162 shares of common stock to cover tax obligations related to vesting restricted stock units.

Progyny's Executive Chairman, David J. Schlanger, purchased 150,000 shares of common stock at a weighted average price of $14.6822 per share.

Progyny's CEO, Peter Anevski, purchased 209,500 shares of common stock at a weighted average price of $14.4825 per share on December 23, 2024.

Progyny Inc.'s President, Michael E. Sturmer, sold 448 shares of common stock to cover tax obligations related to vesting restricted stock units.

Progyny's Chief Financial Officer, Mark S. Livingston, sold 2,617 shares of common stock to cover tax obligations related to vesting restricted stock units.

Progyny's Executive Vice President and General Counsel, Allison Swartz, sold 1,352 shares of common stock to cover tax obligations related to vesting restricted stock units.

Progyny Inc.'s President, Michael E. Sturmer, sold 7,977 shares of common stock to cover tax obligations related to vesting restricted stock units.

Progyny's Chief Financial Officer, Mark S. Livingston, sold 224 shares of common stock to cover tax obligations related to vesting restricted stock units.

David J. Schlanger, Executive Chairman of Progyny, Inc., sold shares to cover withholding taxes upon the vesting of restricted stock units.

Progyny's CEO, Peter Anevski, reports a transaction involving the withholding of shares for tax obligations and discloses beneficial ownership through PECO ANEVSKI 2020 SD LLC.

Michael Sturmer, President of Progyny, Inc., reports the disposition of 448 shares of common stock to cover withholding taxes upon vesting of restricted stock units.